Sang, Y., Lee, R., Luong, A., Katona, É., Whyte, C., Smith, N., Mast, A., Flick, M., Mutch, N., Bergmeier, W., Wolberg, A.: Activated platelets retain and protect most of their factor XIII-A cargo from proteolytic activation and degradation.
Blood Adv. 8 (19), 5072-5085, 2024.

Tóth, E., Orbán-Kálmándi, R., Bagoly, Z., Lóczi, L., Deli, T., Török, O., Deliné Molnár, S., Baráth, S., Singh, P., Hevessy, Z., Katona, É., Fagyas, M., Szabó, A., Molnár, S., Krasznai, Z.: Case report: Complex evaluation of coagulation, fibrinolysis and inflammatory cytokines in a SARS-CoV-2 infected pregnant woman with fetal loss.
Front. Immunol. 15 1-10, 2024.

Kállai, J., Gindele, R., Pénzes-Daku, K., Balogh, G., Kissné Bogáti, R., Bécsi, B., Katona, É., Oláh, Z., Ilonczai, P., Boda, Z., Róna-Tas, Á., Nemes, L., Marton, I., Bereczky, Z.: Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.
Int. J. Mol. Sci. 25 (5), 1-19, 2024.

Katona, T., Tóth, G., Petró, M., Harangi, B.: Developing New Fully Connected Layers for Convolutional Neural Networks with Hyperparameter Optimization for Improved Multi-Label Image Classification.
Mathematics. 12 (6), 1-16, 2024.

Bagoly, Z.: Hemorrhagic transformation after acute ischemic stroke thrombolysis treatment: navigating the landscape of hemostasis genetic risk factors.
Journal of Thrombosis and Haemostasis. 22 (4), 919-921, 2024.

Mátrai, Á., Varga, Á., Baráth, B., Ványolos, E., Orbán-Kálmándi, R., Lóczi, L., Bagoly, Z., Jouppila, A., Lassila, R., Németh, N., Deák, Á.: Heparin-like effect of a dual antiplatelet and anticoagulant (APAC) agent on red blood cell deformability and aggregation in an experimental model.
J Thromb Thrombolysis. [Epub ahead of print]2024.

Bagoly, Z., Lóczi, L., Szegedi, I.: Impact of transcatheter edge-to-edge valve repair on hemostasis in patients with severe mitral regurgitation: key findings from the Mitral Fibrin Study.
Polish Archives of Internal Medicine 134 (7-8), 2024.

Lóczi, L., P. Szabó, R., Orbán-Kálmándi, R., Hodossy-Takács, R., Szilvási, A., Szalai, Z., Nagy, G., Antal-Szalmás, P., Nemes, B., Bagoly, Z.: Increased thrombin generation in kidney transplant recipients with donor-specific antibodies directed against human leukocyte antigens.
Front. Immunol. "Accepted by Publisher"2024.

Pituk, D., Balogh, L., Horváth, E., Hegyi, Z., Baráth, B., Kissné Bogáti, R., Szűcs, P., Papp, Z., Katona, É., Bereczky, Z.: Localization of Hemostasis Elements in Aspirated Coronary Thrombi at Different Stages of Evolution.
Int. J. Mol. Sci. 25 (21), 1-19, 2024.

Ghansah, H., Orbán-Kálmándi, R., Bekéné Debreceni, I., Katona, É., Rejtő, L., Váróczy, L., Lóczi, L., Laat, B., Huskens, D., Kappelmayer, J., Bagoly, Z.: Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma.
Thromb. Res. 234 12-20, 2024.

Balogh, G., Bereczky, Z.: Molecular Mechanisms of the Impaired Heparin Pentasaccharide Interactions in 10 Antithrombin Heparin Binding Site Mutants Revealed by Enhanced Sampling Molecular Dynamics.
Biomolecules. 14 (6), 1-22, 2024.

Kovac, M., Ignjatovic, V., Orlando, C., Bereczky, Z., Hunt, B.: The use of direct oral anticoagulants in the secondary prevention of venous thromboembolism in patients with severe thrombophilia: communication from the ISTH SSC Subcommittee on Physiological Anticoagulants and Thrombophilia.
Journal of Thrombosis and Haemostasis. 22 (11), 3322-3329, 2024.

Kerényi, A., Schlammadinger, Á., Szegedi, I., Kiss, C., Marton, I., Bagoly, Z., Gindele, R., Boda, Z., Kappelmayer, J., Bereczky, Z.: von Willebrand betegség komplex laboratóriumi diagnosztikája egyetemi központban.
Hematol. Trasnzfuziol. 57 (3), 182, 2024.

Natae, S., Merzah, M., Sándor, J., Ádány, R., Bereczky, Z., Fiatal, S.: A combination of strongly associated prothrombotic single nucleotide polymorphisms could efficiently predict venous thrombosis risk.
Front. Cardiovasc. Med. 10 1-11, 2023.

Natorska, J., Corral, J., de la Morena, -., Bravo-Pérez, C., Bagoly, Z., Bereczky, Z., Treliński, J., Witkowski, M., Klajmon, A., Undas, A., Ząbczyk, M.: Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype.
Thromb. Haemost. 123 (9), 880-891, 2023.

Kecskemétiné, G., Zsóri, K., Kőmives, S., Sohajda, M., Csiki, Z., Mátyus, J., Újhelyi, L., Balla, J., Nagy, A., Shemirani, A.: Associations between Genetic Variants in DAB, PRKAG, and DACH Genes and Gender in Chronic Kidney Disease.
Appl. Sci.-Basel. 13 (11), 1-8, 2023.

Somodi, L., Horváth, E., Bárdos, H., Baráth, B., Pethő, D., Katona, É., Balla, J., Mutch, N., Muszbek, L.: Cellular FXIII in Human Macrophage-Derived Foam Cells.
Int. J. Mol. Sci. 24 (5), 1-12, 2023.

Kovács, E., Bereczky, Z., Kerényi, A., Laczik, R., Nagy, V., Kovács, D., Kovács, S., Pfliegler, G.: Clinical investigation of hereditary and acquired thrombophilic factors in patients with venous and arterial thromboembolism.
Int J Gen Med. 16 5425-5437, 2023.

Stercel, V., Lóczi, L., Kadenczki, O., Nemes, É., Nagy, B., Hodossy-Takács, R., Szabó, A., Fagyas, M., Kappelmayer, J., Szabó, T., Bagoly, Z.: Effect of anti-SARS-CoV-2 BNT162b2 mRNA vaccination on thrombin generation in children with inflammatory bowel disease.
Front. Immunol. 14 1-12, 2023.

Árokszállási, T., Balogh, E., Orbán-Kálmándi, R., Pásztor, M., Árokszállási, A., Nagy, E., Belán, I., May, Z., Csépány, T., Csiba, L., Bagoly, Z., Oláh, L.: Elevated Blood Alcohol Concentration Is Associated with Improved Clinical Outcomes of Intravenous Thrombolysis Treatment in Acute Ischemic Stroke Patients: A Retrospective Study.
J Clin Med. 12 (6), 1-13, 2023.

Katona, É.: Functional Consequences of Antibodies against Noncatalytic B Subunit of Factor XIII.
Thromb. Haemost. 123 (9), 855, 2023.

Papp, T., Kiss, Z., Rokszin, G., Fábián, I., Márk, L., Bagoly, Z., Becker, D., Merkely, B., Aradi, D., Dézsi, C., Járai, Z., Csanádi, Z.: Mortality on DOACs Versus on Vitamin K Antagonists in Atrial Fibrillation: Analysis of the Hungarian Health Insurance Fund Database.
Clin. Ther. 45 (4), 333-346, 2023.

Ghansah, H., Bekéné Debreceni, I., Váróczy, L., Rejtő, L., Lóczi, L., Bagoly, Z., Kappelmayer, J.: Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated protein C.
Thromb. Res. 223 44-52, 2023.

Szegedi, K., Szabó, Z., Kállai, J., Király, J., Szabó, E., Bereczky, Z., Juhász, É., Dezső, B., Szász, C., Zsebik, B., Flaskó, T., Halmos, G.: Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors.
J Clin Med. 12 (13), 1-18, 2023.

Pituk, D., Miklós, T., Schlammadinger, Á., Molnárné Rázsó, K., Bereczky, Z.: The association between EPCR gene p.Ser219Gly polymorphism and venous thromboembolism risk: a case-control study, meta-analysis, and a reproducibility study.
Front. Cardiovasc. Med. 10 1-14, 2023.

Balogh, G., Bereczky, Z.: The Interaction of Factor Xa and IXa with Non-Activated Antithrombin in Michaelis Complex: Insights from Enhanced-Sampling Molecular Dynamics Simulations.
Biomolecules. 13 (5), 1-21, 2023.

Bagoly, Z.: ABO blood group type and the risk of venous thromboembolism: the impact of interactions.
Pol. Arch. Intern. Med. 132 (12), 1-2, 2022.

Somodi, L., Bekéné Debreceni, I., Kis, G., Cozzolino, M., Kappelmayer, J., Antal, M., Panyi, G., Bárdos, H., Mutch, N., Muszbek, L.: Activation mechanism dependent surface exposure of cellular factor XIII on activated platelets and platelet microparticles.
J. Thromb. Haemost. 20 (5), 1223-1235, 2022.

Raut, S., Katona, É., Riches-Duit, A., Coxon, C., Muszbek, L., Schroeder, V., Rigsby, P.: An international collaborative study to assign value for Total Factor XIII-B Subunit Antigen to the WHO 1st International Standard for Factor XIII Plasma, (02/206): communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen.
J. Thromb. Haemost. 20 (2), 525-531, 2022.

Fábián, B., Horváth, I., Shemirani, A., Csiki, Z.: Depression and Anxiety Symptoms Are Associated with Mean Platelet Volume in Autoimmune Disorders.
Int. J. Environ. Res. Public Health. 19 (17), 1-9, 2022.

Falanga, A., Leader, A., Ambaglio, C., Bagoly, Z., Castaman, G., Elalamy, I., Lecumberri, R., Niessner, A., Pabinger, I., Szmit, S., Trinchero, A., Ten Cate, H., Rocca, B.: EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer.
HemaSphere. 6 (8), 1-25, 2022.

Sadeghi, F., Sarkady, F., Zsóri, K., Szegedi, I., Orbán-Kálmándi, R., Székely, E., Molnárné Vasas, N., Berényi, E., Csiba, L., Bagoly, Z., Shemirani, A.: High Neutrophil-Lymphocyte Ratio and Low Lymphocyte-Monocyte Ratio Combination after Thrombolysis Is a Potential Predictor of Poor Functional Outcome of Acute Ischemic Stroke.
J. Pers. Med. 12 (8), 1-12, 2022.

Ariens, R., Hunt, B., Agbani, E., Ahnström, J., Ahrends, R., Alikhan, R., Assinger, A., Bagoly, Z., Balduini, A., Barbon, E., Barrett, C., Batty, P., Carneiro, J., Chan, W., de Maat, M., de Wit, K., Denis, C., Ellis, M., Eslick, R., Fu, H., Hayward, C., Ho-Tin-Noé, B., Klok, F., Kumar, R., Leiderman, K., Litvinov, R., Mackman, N., McQuilten, Z., Neal, M., Parker, W., Preston, R., Rayes, J., Rezaie, A., Roberts, L., Rocca, B., Shapiro, S., Siegal, D., Sousa, L., Suzuki-Inoue, K., Zafar, T., Zhou, J.: Illustrated State-of-the-Art Capsules of the 2022 Congress.
Res Pract Thromb Haemost. 6 (5), 1-45, 2022.

Szabó, G., Antal-Szalmás, P., Kerényi, A., Pénzes-Daku, K., Bécsi, B., Kappelmayer, J.: Laboratory Approaches to Test the Function of Antiphospholipid Antibodies.
Semin. Thromb. Hemost. 48 (2), 132-144, 2022.

Székely, E., Orbán-Kálmándi, R., Szegedi, I., Katona, É., Baráth, B., Czuriga-Kovács, K., Lóczi, L., Molnárné Vasas, N., Fekete, I., Fekete, K., Berényi, E., Oláh, L., Csiba, L., Bagoly, Z.: Low [alfa]2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis.
Front. Cardiovasc. Med. 9 1-14, 2022.

Herczeg, M., Demeter, F., Lisztes, E., Racskó, M., Tóth, I., Timári, I., Bereczky, Z., Kövér, K., Borbás, A.: Synthesis of a Heparinoid Pentasaccharide Containing L-Guluronic Acid Instead of L-Iduronic Acid with Preserved Anticoagulant Activity.
J. Org. Chem. 87 (23), 15830-15836, 2022.

Kissné Bogáti, R., Katona, É., Shemirani, A., Balogh, E., Bárdos, H., Jeney, V., Muszbek, L.: The Effect of Activated FXIII, a Transglutaminase, on Vascular Smooth Muscle Cells.
Int. J. Mol. Sci. 23 (10), 1-15, 2022.

Nagy, I., Baráth, B., Mangó, K., Shemirani, A., Monostory, K., Nemes, B.: The Prognostic Role of CYP Enzyme in Kidney Transplantation: A Single Centre Experience.
Transplant. Proc. 54 (9), 2584-2588, 2022.

Lóczi, L., Orbán-Kálmándi, R., Árokszállási, T., Fekete, I., Fekete, K., Héja, M., Tóth, J., Csiba, L., Bagoly, Z.: Thrombin generation as a predictor of outcomes in patients with non-traumatic intracerebral hemorrhage.
Front. Neurol. 13 1-12, 2022.

Bereczky, Z., Gindele, R., Fiatal, S., Speker, M., Miklós, T., Balogh, L., Mezei, Z., Szabó, Z., Ádány, R.: Age and Origin of the Founder Antithrombin Budapest 3 (p.Leu131Phe) Mutation; Its High Prevalence in the Roma Population and Its Association With Cardiovascular Diseases.
Front. Cardiovasc. Med. 7 1-15, 2021.

Orbán-Kálmándi, R., Szegedi, I., Sarkady, F., Fekete, I., Fekete, K., Molnárné Vasas, N., Berényi, E., Csiba, L., Bagoly, Z.: A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis.
Sci. Rep. 11 (1), 1-14, 2021.

Orbán-Kálmándi, R., Árokszállási, T., Fekete, I., Fekete, K., Héja, M., Tóth, J., Sarkady, F., Csiba, L., Bagoly, Z.: A Modified in vitro Clot Lysis Assay Predicts Outcomes in Non-traumatic Intracerebral Hemorrhage Stroke Patients: the IRONHEART Study.
Front. Neurol. 12 1-11, 2021.

Wieringa, G., Queralto, J., Homšak, E., Jassam, N., Cavalier, E., Svinarov, D., Krleža, J., Christou, S., Pikner, R., Larsen, T., Tomberg, K., Linko-Parvinen, A., Sapin, V., Baum, H., Kroupis, C., Bagoly, Z., Costelloe, S., Sciacovelli, L., Stasulans, J., Vitkus, D., Meunier, D., Solnica, B., Reguengo, H., Mambet, C., Kovac, G., Krhin, B., Ohlson, M., Buhagiar, G., Simundic, A.: A proposed common training framework for specialists in laboratory medicine under EU directive 2013/55/EC (The recognition of professional qualifications).
Clin. Chem. Lab. Med. 59 (3), 505-512, 2021.

Kovács, A., Tajti, B., Szoboszlay, I., Bereczky, Z., Ilonczai, P.: A szerzett haemophilia A sikeres kezelése.
Orv. hetil. 162 (49), 1977-1981, 2021.

Balogh, G., Gyöngyösi, T., Timári, I., Herczeg, M., Borbás, A., Sadiq, S., Fehér, K., Kövér, K.: Conformational Analysis of Heparin-Analogue Pentasaccharides by Nuclear Magnetic Resonance Spectroscopy and Molecular Dynamics Simulations.
J. Chem Inf. Model. 61 (6), 2926-2936, 2021.

Major, T., Bereczky, Z., Gindele, R., Balogh, G., Rácz, B., Bora, L., Kézsmárki, Z., Brúgós, B., Pfliegler, G.: Current Status of Clinical and Genetic Screening of Hereditary Hemorrhagic Telangiectasia Families in Hungary.
J Clin Med. 10 (17), 1-17, 2021.

Szegedi, I., Orbán-Kálmándi, R., Nagy, A., Sarkady, F., Molnárné Vasas, N., Sik, M., Lánczi, L., Berényi, E., Oláh, L., Crișan, A., Csiba, L., Bagoly, Z.: Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.
PLoS One. 16 (7), 1-16, 2021.

Magyari, F., Kracskó, B., Bedekovics, J., Bereczky, Z., Illés, Á., Schlammadinger, Á.: Differential diagnostic and treatment difficulties in a patient with acquired von Willebrand syndrome.
Hematology. 26 (1), 301-304, 2021.

Bagoly, Z., Behme, D., Kaesmacher, J., Martinez De Lizarrondo, S.: Editorial: hemostasis and Stroke.
Front. Neurol. 12 1-4, 2021.

Baráth, B., Kissné Bogáti, R., Miklós, T., Kállai, J., Mezei, Z., Bereczky, Z., Muszbek, L., Katona, É.: Effect of [alfa]2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
Thromb. Res. 203 110-116, 2021.

Baráth, B., Somogyi, V., Tánczos, B., Varga, Á., Bereczky, Z., Németh, N., Deák, Á.: Examination of the relation between red blood cell aggregation and hematocrit in human and various experimental animals.
Clin. Hemorheol. Microcirc. 78 (2), 187-198, 2021.

Major, T., Gindele, R., Balogh, G., Bárdossy, P., Bereczky, Z.: Founder Effects in Hereditary Hemorrhagic Telangiectasia.
J Clin Med. 10 (8), 1-20, 2021.

Plamenova, I., Zolkova, J., Sokol, J., Kolkova, Z., Bereczky, Z., Katona, É., Muszbek, L., Kubisz, P., Staško, J.: Genetic Background of Inherited Factor XIII-A Subunit Deficiency: review of the Literature and Description of Two New Cases.
Semin. Thromb. Hemost. 47 (7), 885-889, 2021.

Morena-Barrio, M., Gindele, R., Bravo-Pérez, C., Ilonczai, P., Zuazu, I., Speker, M., Oláh, Z., Rodríguez-Sevilla, J., Entrena, L., Infante, M., Morena-Barrio, B., García, J., Schlammadinger, Á., Cifuentes-Riquelme, R., Mora, -., Miñano, A., Padilla, J., Vicente, V., Corral, J., Bereczky, Z.: High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: description of a new syndrome.
Am. J. Hematol. 96 (11), 1363-1373, 2021.

Bagoly, Z., Baráth, B., Orbán-Kálmándi, R., Szegedi, I., Kissné Bogáti, R., Sarkady, F., Csiba, L., Katona, É.: Incorporation of [alfa]2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients.
Biomolecules. 11 (3), 1-13, 2021.

Gindele, R., Pénzes-Daku, K., Balogh, G., Kállai, J., Kissné Bogáti, R., Bécsi, B., Erdődi, F., Katona, É., Bereczky, Z.: Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods.
Biomolecules. 11 (4), 1-18, 2021.

Mátrai, Á., Varga, G., Tánczos, B., Baráth, B., Varga, Á., Horváth, L., Bereczky, Z., Deák, Á., Németh, N.: In vitro effects of temperature on red blood cell deformability and membrane stability in human and various vertebrate species.
Clin. Hemorheol. Microcirc. 78 (3), 291-300, 2021.

Krasznai, Z., Bagoly, Z., Nagy, E., Farkas, Z., Póka, R., Török, P., Lampé, R., Hernádi, Z.: Multimodális hyper-spektroszkópia: előrelépés a digitális technológia felé a méhnyakrákszűrésben.
Orv. hetil. 162 (20), 790-799, 2021.

Fekete, K., Tóth, J., Horváth, L., Márton, S., Héja, M., Csiba, L., Árokszállási, T., Bagoly, Z., Sulina, D., Fekete, I.: Neurophysiological examinations as adjunctive tool to imaging techniques in spontaneous intracerebral haemorrhage: IRONHEART study.
Front. Neurol. 12 1-15, 2021.

Árokszállási, T., Héja, M., Bagoly, Z., Kovács, K., Orbán-Kálmándi, R., Sarkady, F., Tóth, J., Fekete, K., Fekete, I., Csiba, L.: Prognostic value of various hemostasis parameters and neurophysiological examinations in spontaneous intracerebral hemorrhage: the IRONHEART study protocol.
Front. Neurol. 12 1-6, 2021.

Gindele, R., Kerényi, A., Kállai, J., Pfliegler, G., Schlammadinger, Á., Szegedi, I., Major, T., Szabó, Z., Bagoly, Z., Kiss, C., Kappelmayer, J., Bereczky, Z.: Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing.
Life (Basel). 11 (3), 1-23, 2021.

Reményi, G., Bereczky, Z., Gindele, R., Ujfalusi, A., Illés, Á., Udvardy, M.: rs779805 Von Hippel-Lindau Gene Polymorphism Induced/Related Polycythemia Entity, Clinical Features, Cancer Association, and Familiar Characteristics.
Pathol. Oncol. Res. 27 1-6, 2021.

Natae, S., Kósa, Z., Sándor, J., Merzah, M., Bereczky, Z., Pikó, P., Ádány, R., Fiatal, S.: The Higher Prevalence of Venous Thromboembolism in the Hungarian Roma Population Could Be Due to Elevated Genetic Risk and Stronger Gene-Environmental Interactions.
Front. Cardiovasc. Med. 8 1-13, 2021.

Kaucsár, T., Jávorszky, E., Antal, V., Madar, L., Balogh, I., Tory, K.: Vese-coloboma szindróma: PAX2 mutáció nyomában.
Gyermekgyógyászat 72 (3), 225-225, 2021.

Lóczi, L., Kappelmayer, J., Tarr, T., Bagoly, Z.: Antiphospholipid syndrome and the risk of myocardial infarction: current evidence and uncertainties.
Kardiol. Pol. 78 (1), 6-14, 2020.

Bovet, J., Hurják, B., Maistre, E., Katona, É., Pénzes-Daku, K., Muszbek, L.: Autoimmune Factor XIII Deficiency With Unusual Laboratory and Clinical Phenotype.
J. Thromb. Haemost. 18 (6), 1330-1334, 2020.

Szabó, G., Pénzes-Daku, K., Torner, B., Fagyas, M., Tarr, T., Soltész, P., Kis, G., Antal, M., Kappelmayer, J.: Distinct and overlapping effects of [beta]2-glycoprotein I conformational variants in ligand interactions and functional assays.
J. Immunol. Methods. 487 112877, 2020.

Santoso, C., Bramantoro, T., Nguyen, M., Bagoly, Z., Nagy, A.: Factors Affecting Dental Service Utilisation in Indonesia: a Population-Based Multilevel Analysis.
Int. J. Environ. Res. Public Health. 17 (15), 1-11, 2020.

Hajas, O., Bagoly, Z., Tóth, N., Urbancsek, R., Kiss, A., Kovács, K., Sarkady, F., Nagy, A., Oláh, A., Nagy, L., Clemens, M., Csiba, L., Csanádi, Z.: Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques.
Cardiol Res Pract. 2020 1-8, 2020.

Majer, R., Adeyi, O., Bagoly, Z., Simon, V., Csiba, L., Kardos, L., Hortobágyi, T., Frecska, E.: Neuropsychiatric symptoms, quality of life and caregivers' burden in dementia.
Open Med. 15 (1), 905-914, 2020.

Hurják, B., Kovács, Z., Döncző, B., Katona, É., Haramura, G., Erdélyi, F., Shemirani, A., Sadeghi, F., Muszbek, L., Guttman, A.: N-glycosylation of blood coagulation factor XIII subunit B and its functional consequence.
J. Thromb. Haemost. 18 (6), 1302-1309, 2020.

Fekete, A., Komáromi, I., Mucs, D.: On the early events of the calcium induced activation of coagulation factor XIII-A2 and tissue transglutaminase: an in silico study.
J. Biomol. Struct. Dyn. 38 (1), 152-167, 2020.

Major, T., Csobay-Novák, C., Gindele, R., Szabó, Z., Bora, L., Jóni, N., Rácz, T., Karosi, T., Bereczky, Z.: Pitfalls of delaying the diagnosis of hereditary haemorrhagic telangiectasia.
J. Int. Med. Res. 48 (2), 1-7, 2020.

Ząbczyk, M., Natorska, J., Bagoly, Z., Sarkady, F., Baráth, B., Katona, É., Bryk, A., Zettl, K., Wisniewski, J., Undas, A.: Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months' anticoagulation since the acute phase.
J. Physiol. Pharmacol. 71 (4), 519-524, 2020.

Sadeghi, F., Kovács, S., Zsóri, K., Csiki, Z., Bereczky, Z., Shemirani, A.: Platelet count and mean volume in acute stroke: a systematic review and meta-analysis.
Platelets. 31 (6), 731-739, 2020.

Tsuda, H., Noguchi, K., Oh, D., Bereczky, Z., Lee, L., Kang, D., Dusse, L., Carvalho, M., Morishita, E., SSC Subcommittee on Plasma Coagulation Inhibitors of the ISTH: Racial differences in protein S Tokushima and two protein C variants as genetic risk factors for venous thromboembolism.
Res. Pract. Thromb. Haemost. 4 (8), 1295-1300, 2020.

Bryk, A., Siudut, J., Broniatowska, E., Bagoly, Z., Baráth, B., Katona, É., Undas, A.: Sex-specific alteration to α2-antiplasmin incorporation in patients with type 2 diabetes.
Thromb. Res. 185 88-62, 2020.

Szegedi, I., Orbán-Kálmándi, R., Csiba, L., Bagoly, Z.: Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: a Narrative and Systematic Review of the Literature.
J Clin Med. 9 (10), 3137-3148, 2020.

Bege, M., Bereczki, I., Molnár, D., Kicsák, M., Pénzes-Daku, K., Bereczky, Z., Ferenc, G., Kovács, L., Herczegh, P., Borbás, A.: Synthesis and oligomerization of cysteinyl nucleosides.
Org. Biomol. Chem. 18 8161-8178, 2020.

Pénzes-Daku, K., Hurják, B., Katona, É., Becs, G., Balla, J., Muszbek, L.: Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment.
Int. J. Mol. Sci. 21 1-15, 2020.

Kattula, S., Bagoly, Z., Tóth, N., Muszbek, L., Wolberg, A.: The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
J. Thromb. Haemost. 18 (4), 885-894, 2020.

Balogh, G., Komáromi, I., Bereczky, Z.: The mechanism of high affinity pentasaccharide binding to antithrombin, insights from Gaussian accelerated molecular dynamics simulations.
J. Biomol. Struct. Dyn. 38 (16), 4718-4732, 2020.

Major, T., Gindele, R., Szabó, Z., Kis, Z., Bora, L., Jóni, N., Bárdossy, P., Rácz, T., Bereczky, Z.: The Stratified Population Screening of Hereditary Hemorrhagic Telangiectasia.
Pathol. Oncol. Res. 26 (4), 2783-2788, 2020.

Bagoly, Z., Hajas, O., Urbancsek, R., Kiss, A., Fiák, E., Sarkady, F., Tóth, N., Orbán-Kálmándi, R., Kovács, K., Nagy, L., Nagy, A., Kappelmayer, J., Csiba, L., Csanádi, Z.: Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists during Cryoballoon Catheter Ablation of Atrial Fibrillation.
J Clin Med. 9 (9), 1-13, 2020.

Major, T., Gindele, R., Szabó, Z., Jóni, N., Kis, Z., Bora, L., Bárdossy, P., Rácz, T., Karosi, T., Bereczky, Z.: A herediter haemorrhagiás teleangiectasia (Osler-Weber-Rendu-kór) genetikai diagnosztikája.
Orv. hetil. 160 (18), 710-719, 2019.

Orosz, A., Csapó, A., Bagoly, Z., Székely, E., Tóth, E., Kovács, B., Bereczky, Z., Muszbek, L., Katona, É.: A new ELISA method for the measurement of total α2-plasmin inhibitor level in human body fluids.
J. Immunol. Methods. 471 27-33, 2019.

Orosz, Z., Bárdos, H., Shemirani, A., Bekéné Debreceni, I., Lassila, R., Riikonen, A., Kremer Hovinga, J., Seiler, T., van Dorland, H., Schroeder, V., Boda, Z., Nemes, L., Früh Eppstein, B., Nagy, B., Facskó, A., Kappelmayer, J., Muszbek, L.: Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes.
Int. J. Mol. Sci. 20 (23), 1-17, 2019.

Kovács, S., Csiki, Z., Zsóri, K., Bereczky, Z., Shemirani, A.: Characteristics of platelet count and size and diagnostic accuracy of mean platelet volume in patients with venous thromboembolism: a systematic review and meta-analysis.
Platelets. 30 (2), 139-147, 2019.

Balogh, G., Gyöngyösi, T., Timári, I., Herczeg, M., Borbás, A., Fehér, K., Kövér, K.: Comparison of Carbohydrate Force Fields Using Gaussian Accelerated Molecular Dynamics Simulations and Development of Force Field Parameters for Heparin-Analogue Pentasaccharides.
J. Chem Inf. Model. 59 (11), 4855-4867, 2019.

Bagoly, Z., Muszbek, L.: Factor XIII: what does it look like?.
J. Thromb. Haemost. 17 (5), 714-716, 2019.

Andrásdi, Z., Pénzes-Daku, K.: Felszíni plazmon rezonancia - diagnosztikai kiegészítés inhibitoros faktorhiányban.
Gyermekgyógy. 70 (1), 14-18, 2019.

Balogh, G., Muszbek, L., Komáromi, I.: First Step of the Transglutaminase Reaction Catalyzed by Activated Factor XIII Subunit A, Hybrid Quantum Chemistry/Molecular Mechanics Calculations.
J. Phys. Chem. B. 123 (18), 3887-3897, 2019.

Kovac, M., Mitic, G., Djilas, I., Kuzmanovic, M., Serbic, O., Lekovic, D., Tomic, B., Bereczky, Z.: Genotype phenotype correlation in a pediatric population with antithrombin deficiency.
Eur. J. Pediatr. 178 (10), 1471-1478, 2019.

Árokszállási, T., Bagoly, Z., Fekete, K., Fekete, I., Szegedi, I., Andrejkovics, M., Tóth, J., Csiba, L.: Hemostasis biomarkers in the prognosis of non-traumatic intracerebral hemorrhage.
Eur. Stroke J. 4 (Suppl.), 449, 2019.

Bereczky, Z., Balogh, L., Bagoly, Z.: Inherited thrombophilia and the risk of myocardial infarction: current evidence and uncertainties.
Kardiol. Pol. 77 (4), 419-429, 2019.

Bagoly, Z., Szegedi, I., Orbán-Kálmándi, R., Tóth, N., Csiba, L.: Markers of Coagulation and Fibrinolysis Predicting the Outcome of Acute Ischemic Stroke Thrombolysis Treatment: a Review of the Literature.
Front. Neurol. 10 1-13, 2019.

Salamon, A., Faragó, P., Németh, V., Szépfalusi, N., Horváth, E., Vass, A., Bereczky, Z., Tajti, J., Vécsei, L., Klivényi, P., Zádori, D.: Multiplex ischaemiás stroke Osler-Rendu-Weber-kórban.
Ideggyogy. Szle. 72 (1-2), 65-70, 2019.

Szegedi, I., Nagy, A., Székely, E., Czuriga-Kovács, K., Sarkady, F., Lánczi, L., Berényi, E., Csiba, L., Bagoly, Z.: PAI-1 5G/5G genotype is an independent risk of intracranial hemorrhage in post-lysis stroke patients.
Ann. Clin. Trans. Neurol. 6 (11), 2240-2250, 2019.

Szegedi, I., Árokszállási, T., Fekete, I., Fekete, K., Nagy, A., Sarkady, F., Székely, E., Czuriga-Kovács, K., Berényi, E., Bagoly, Z., Csiba, L.: The association of plasminogen activator inhibitor-1 (pai-1) 4g/5g polymorphism with the risk and prognosis of intracerebral hemorrhage.
Eur. Stroke J. 4 (Suppl.), 470, 2019.

Kovac, M., Mitic, G., Mikovic, Z., Mandic, V., Miljic, P., Mitrovic, M., Tomic, B., Bereczky, Z.: The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications.
Thromb. Res. 173 12-19, 2019.

Orbán-Kálmándi, R., Szegedi, I., Fekete, I., Fekete, K., Sarkady, F., Varga, L., Csiba, L., Bagoly, Z.: The use of ex vivo clot lysis assay for predicting outcomes in acute ischemic stroke patients who underwent intravenous thrombolysis.
Eur. Stroke J. 4 (Suppl.), 742-743, 2019.

Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z., Bereczky, Z.: ALPHA-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism in Patients with Venous Thromboembolism.
Proceedings. 2 (9), 102-103, 2018.

Bagoly, Z.: Altered fibrin clot phenotype as predictor of the risk of recurrent venous thromboembolism: evidence is growing.
Pol. Arch. Intern. Med. 128 (10), 569-571, 2018.

Muszbek, L., Katona, É., Pénzes-Daku, K.: Antibodies against factor XIII subunits.
In: Factor XIII Clinical and Laboratory Aspects - ECAT Foundation. Eds.: Helena Laboratories, ECAT Foundation, Voorschoten, 17-21, 2017.

Muszbek, L., Pénzes-Daku, K., Katona, É.: Auto-, and alloantibodies against factor XIII: laboratory diagnosis and clinical consequences.
J. Thromb. Haemost. 16 (5), 822-832, 2018.

Balogh, L., Katona, É., Mezei, Z., Kállai, J., Gindele, R., Édes, I., Muszbek, L., Papp, Z., Bereczky, Z.: Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.
Mol. Cell. Biochem. 448 (1-2), 199-209, 2018.

Miklós, T., Balla, G., Balogh, L., Boda, Z., Szabó, Z., Molnár, É., Gindele, R., Katona, É., Bereczky, Z.: Effects of Serpinc1, Proc, Pros1 and Epcr Polymorphisms on the Plasma Levels of Natural Anticoagulants in Healthy Individuals and on the Risk of Venous Thromboembolism and Myocardial Infarction.
Proceedings. 2 (9), 78, 2018.

Miklós, T., Balla, G., Balogh, L., Boda, Z., Szabó, Z., Molnár, É., Gindele, R., Katona, É., Bereczky, Z.: Effects of SERPINC1, PROC, PROS1 and EPCR Polymorphisms on the Risk of Venous Thromboembolism and Myocardial Infarction in Young Individuals.
Res Pract Thromb Haemost. 2 178, 2018.

Tóth, N., Székely, E., Czuriga-Kovács, K., Sarkady, F., Nagy, O., Lánczi, L., Berényi, E., Fekete, K., Fekete, I., Csiba, L., Bagoly, Z.: Elevated factor VIII and von Willebrand factor levels predict unfavorable outcome in stroke patients treated with intravenous thrombolysis.
Front. Neurol. 8 1-10, 2018.

Kovac, M., Mitic, G., Lalic-Cosic, S., Djordjevic, V., Tomic, B., Muszbek, L., Bereczky, Z.: Evaluation of endogenous thrombin potential among patients with antithrombin deficiency.
Thromb. Res. 166 50-53, 2018.

Kovac, M., Mitic, G., Lalic-Cosic, S., Djordjevic, V., Tomic, B., Bereczky, Z.: Evaluation of Endogenous Thrombin Potential among Patients with Antithrombin Deficiency-Serbian at Deficiency Study Group Results.
Proceedings. 2 (9), 74-75, 2018.

Schroeder, V., Bereczky, Z., Kohler, H.: Factor XIII in thrombotic diseases.
In: Factor XIII Clinical and Laboratory Aspects - ECAT Foundation. Eds.: Helena Laboratories, ECAT Foundation, Voorschoten, 8-12, 2017.

Baráth, B., Bagoly, Z., Szegedi, I., Orbán-Kálmándi, R., Csiba, L., Katona, É.: Incorporation of Alpha-2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients Receiving Thrombolytic Therapy.
Proceedings. 2 (9), 101-102, 2018.

Székely, E., Czuriga-Kovács, K., Bereczky, Z., Katona, É., Mezei, Z., Nagy, A., Tóth, N., Berényi, E., Muszbek, L., Csiba, L., Bagoly, Z.: Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients.
Sci. Rep. 8 (1), 1-9, 2018.

Nánási, P., Komáromi, I., Gaburjakova, M., Almássy, J.: Omecamtiv Mecarbil: a Myosin Motor Activator Agent with Promising Clinical Performance and New in vitro Results.
Curr. Med. Chem. 25 (15), 1720-1728, 2018.

Nánási, P., Komáromi, I., Almássy, J.: Perspectives of a myosin motor activator agent with increased selectivity.
Can. J. Physiol. Pharmacol. 96 (7), 676-680, 2018.

Gindele, R., Colombo, R., Szabó, Z., Speker, M., Mezei, Z., Balogh, L., Katona, É., Bagoly, Z., Fiatal, S., Bereczky, Z.: Prevalence of Antithrombin Budapest 3 Mutation among Different Patients Groups; Investigation of the Age and Origin of Mutation Common in Hungary.
Proceedings. 2 (9), 76-77, 2018.

Demeter, F., Gyöngyösi, T., Bereczky, Z., Kövér, K., Herczeg, M., Borbás, A.: Replacement of the L-iduronic acid unit of the anticoagulant pentasaccharide idraparinux by a 6-deoxy-L-talopyranose: synthesis and conformational analysis.
Sci Rep. 8 (1), 1-10, 2018.

Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z., Bereczky, Z.: The Effect of Alpha-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism on the Risk of Venous Thromboembolism.
Res Pract Thromb Haemost. 2 324-324, 2018.

Bagoly, Z., Baráth, B., Szegedi, I., Orbán-Kálmándi, R., Csiba, L., Katona, É.: The Effect of Factor XIII Levels on the Incorporation of [alfa]2-plasmin Inhibitor into Fibrin Clots: association with the Therapeutic Outcome of Acute Ischemic Stroke Patients.
Res. Pract. Thromb. Haemost. 2 198-198, 2018.

Katona, É., Muszbek, L.: The laboratory diagnosis of inherited FXIII deficiencies and the measurement of FXIII activity and antigen level.
In: Factor XIII Clinical and Laboratory Aspects - ECAT Foundation. Eds.: Helena Laboratories, ECAT Foundation, Voorschoten, 22-26, 2017.

Selmeczi, A., Gindele, R., Ilonczai, P., Fekete, A., Komáromi, I., Schlammadinger, Á., Molnárné Rázsó, K., Kovács, K., Bárdos, H., Ádány, R., Muszbek, L., Bereczky, Z., Boda, Z., Oláh, Z.: Antithrombin Debrecen (p.Leu205Pro) - Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency.
Thromb. Res. 158 1-7, 2017.

Muszbek, L., Katona, É., Kerényi, A.: Assessment of Factor XIII.
In: Hemostasis and Thrombosis. Eds.: Emmanuel J. Favaloro, Giuseppe Lippi, Humana Press Inc., New York, 277-297, 2017. ISBN: 9781493971947

Kocsis, A., Tóth, J.: Az Emberi Erőforrások Minisztériuma szakmai irányelve a rutin laboratóriumi vizsgálatok preanalitikai folyamatairól.

Bereczky, Z., Oláh, Z., Ajzner, É., Kappelmayer, J.: Az új orális antikoagulánsokkal történő kezelés laboratóriumi vonatkozásai.
Orvosi Hetilap. 158 (49), 1930-1945, 2017.

Gindele, R., Selmeczi, A., Oláh, Z., Ilonczai, P., Pfliegler, G., Marján, E., Nemes, L., Nagy, Á., Losonczy, H., Mitic, G., Kovac, M., Balogh, G., Komáromi, I., Schlammadinger, Á., Molnárné Rázsó, K., Boda, Z., Muszbek, L., Bereczky, Z.: Clinical and laboratory characteristics of antithrombin deficiencies: a large cohort study from a single diagnostic center.
Thromb. Res. 160 119-128, 2017.

Bagoly, Z., Ariens, R., Rijken, D., Pieters, M., Wolberg, A.: Clot Structure and Fibrinolysis in Thrombosis and Hemostasis.
Biomed Res. Int. 2017 1-2, 2017.

Kovac, M., Mitic, G., Jesic, M., Djordjevic, V., Muszbek, L., Bereczky, Z.: Early onset of abdominal venous thrombosis in a newborn with homozygous type II heparin-binding site antithrombin deficiency.
Blood Coagul. Fibrinolysis. 28 (3), 264-266, 2017.

Kerényi, A., Bekéné Debreceni, I., Oláh, Z., Ilonczai, P., Bereczky, Z., Nagy, B., Muszbek, L., Kappelmayer, J.: Evaluation of flow cytometric HIT assays in relation to an IgG-specific immunoassay and clinical outcome.
Cytom. Part B-Clin. Cytom. 92 (5), 389-397, 2017.

Mezei, Z., Katona, É., Kállai, J., Bereczky, Z., Somodi, L., Molnár, É., Kovács, B., Miklós, T., Ajzner, É., Muszbek, L.: Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
Thromb. Res. 158 93-97, 2017.

Amir-Houshang, S., Zsóri, K., Jávor, A., Csiki, Z.: Genetics in Peripheral Artery Disease.
In: Peripheral Arterial Disease - A Practical Approach. Ed.: Sareen Nishtha, [s.n.], [s.n.], 107-116, 2018. ISBN: 9781789842173

Tóth, N., Csanádi, Z., Hajas, O., Kiss, A., Nagy-Baló, E., Kovács, K., Sarkady, F., Muszbek, L., Bereczky, Z., Csiba, L., Bagoly, Z.: Intracardiac hemostasis and fibrinolysis parameters in patients with atrial fibrillation.
Biomed Res. Int. 2017 1-10, 2017.

Sárközi, S., Komáromi, I., Jóna, I., Almássy, J.: Lanthanides Report Calcium Sensor in the Vestibule of Ryanodine Receptor.
Biophys. J. 112 (10), 2127-2137, 2017.

Hudák, R., Székely, E., Czuriga-Kovács, K., Nagy, A., Hofgárt, G., Berényi, E., Csiba, L., Kappelmayer, J., Bagoly, Z.: Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis.
PLoS One. 12 (7), 1-13, 2017.

Menegatti, M., Palla, R., Boscarino, M., Bucciarelli, P., Muszbek, L., Katona, É., Makris, M., Peyvandi, F.: Minimal factor XIII activity level to prevent major spontaneous bleeds.
J. Thromb. Haemost. 15 1728-1736, 2017.

Kun, M., Szuber, N., Katona, É., Pénzes-Daku, K., Bonnefoy, A., Bécsi, B., Erdődi, F., Rivard, G., Muszbek, L.: Severe bleeding diatheses in an elderly patient with combined type autoantibody against factor XIII A subunit: novel approach to the diagnosis and classification of anti-factor XIII antibodies.
Haemophilia. 23 (4), 590-597, 2017.

Bagoly, Z.: Uncovering the genetic background of natural anticoagulant deficiencies: time to look behind the scenes.
Pol. Arch. Med. Wewn. 127 (7-8), 465-467, 2017.

Pénzes-Daku, K., Vezina, C., Bereczky, Z., Katona, É., Kun, M., Muszbek, L., Rivard, G.: Alloantibody developed in a factor XIII A subunit deficient patient during substitution therapy: characterization of the antibody.
Haemophilia. 22 (2), 268-275, 2016.

Bereczky, Z., Gindele, R., Speker, M., Kállai, J.: Deficiencies of the natural anticoagulants: novel clinical laboratory aspects of thrombophilia testing.
EJIFCC. 27 (2), 130-146, 2016.

Muszbek, L., Katona, É.: Diagnosis and Management of Congenital and Acquired FXIII Deficiencies.
Semin. Thromb. Hemost. 42 429-439, 2016.

Bereczky, Z., Speker, M., Gindele, R., Szabó, Z., Oláh, Z., Pfliegler, G., Kerényi, A., Boda, Z.: Diagnostic issues in antithrombin, protein C and protein S deficiency in the hungarian population: experience of a large thrombosis laboratory.
J. Throm. Haemost. 14 (Suppl.), 98, 2016.

Major, T., Gindele, R., Szabó, Z., Alef, T., Thiele, B., Bora, L., Kis, Z., Bárdossy, P., Rácz, T., Havacs, I., Bereczky, Z.: Evidence for the founder effect of a novel ACVRL1 splice-site mutation in Hungarian hereditary hemorrhagic telangiectasia families.
Clin. Genet. 90 (5), 466-467, 2016.

Gindele, R., Oláh, Z., Ilonczai, P., Speker, M., Udvari, Á., Selmeczi, A., Pfliegler, G., Marján, E., Kovács, B., Boda, Z., Muszbek, L., Bereczky, Z.: Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.
J. Thromb. Haemost. 14 (4), 704-715, 2016.

Bagoly, Z., Homoródi, N., Kovács, E., Sarkady, F., Csiba, L., Édes, I., Muszbek, L.: How to test the effect of aspirin and clopidogrel in patients on dual antiplatelet therapy?.
Platelets. 27 (1), 59-65, 2016.

Fekete, A., Komáromi, I.: Modeling the archetype cysteine protease reaction using dispersion corrected density functional methods in ONIOM-type hybrid QM/MM calculations: the proteolytic reaction of papain.
Phys. Chem. Chem. Phys. 18 (48), 32847-32861, 2016.

Pénzes-Daku, K., Molnárné Rázsó, K., Katona, É., Kerényi, A., Kun, M., Muszbek, L.: Neutralizing autoantibody against factor XIII A subunit resulted in severe bleeding diathesis with a fatal outcome: characterization of the antibody.
J. Thromb. Haemost. 14 (8), 1517-1520, 2016.

Kovac, M., Mitic, G., Mikovic, Z., Djordjevic, V., Muszbek, L., Bereczky, Z.: Pregnancy related stroke in the setting of homozygous type-II HBS antithrombin deficiency.
Thromb. Res. 139 111-113, 2016.

Csomós, K., Kristóf, E., Márkus, B., Csomós, I., Kovács, G., Rotem, O., Hodrea, J., Bagoly, Z., Muszbek, L., Balajthy, Z., Csősz, É., Fésüs, L.: Protein cross-linking by chlorinated polyamines and transglutamylation stabilizes neutrophil extracellular traps.
Cell Death Dis. 7 (8), e2332, 2016.

Mezei, Z., Katona, É., Kállai, J., Bereczky, Z., Molnár, É., Kovács, B., Ajzner, É., Bagoly, Z., Miklós, T., Muszbek, L.: Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.
Thromb. Res. 148 101-106, 2016.

Eszenyi, D., Mándi, A., Herczeg, M., Bényei, A., Komáromi, I., Borbás, A.: Synthesis of C-2- and C-3-Sulfonatomethyl O- and S-Glycosides by Horner-Wadsworth-Emmons Olefination.
Eur. J. Org. Chem. 2016 (22), 3884-3893, 2016.

Homoródi, N., Kovács, E., Leé, S., Katona, É., Shemirani, A., Haramura, G., Balogh, L., Bereczky, Z., Szőke, G., Péterfy, H., Kiss, R., Édes, I., Muszbek, L.: The lack of aspirin resistance in patients with coronary artery disease.
J. Transl. Med. 14 (1), 74, 2016.

Bereczky, Z.: A véralvadás genetikai eredetű zavarai.
In: Klinikai Genetika. Szerk.: Oláh Éva, Medicina Könyvkiadó Zrt., Budapest, 487-500, 2015. ISBN: 9789632265407

Bagoly, Z.: Cancer and thrombosis: a fresh look at an old story.
Thromb. Res. 136 1-2, 2015.

Gyöngyösi, T., Komáromi, I., Kövér, K.: Heparin-analóg pentaszacharidok antitrombin-III fehérjével való kölcsönhatásának összehasonlítása nmr spektroszkópiai módszerek és molekuladinamikai számítások segítségével.
In: XXXVIII. Kémiai Előadói Napok : Program és előadás-összefoglalók. Szerk.: Bohner Bíborka, Mesterházy Edit, JATEPress, Szeged, 150-151, 2015. ISBN: 9789639970649

Gebhard, J., Laczkovics, C., Posch, F., Ay, C., Reitter-Pfoertner, S., Haslacher, H., Muszbek, L., Wolberg, A., Pabinger, I.: Plasma clot properties in patients with a mild-to-moderate bleeding tendency of unknown cause.
Ann. Hematol. 94 (8), 1301-1310, 2015.

Papp, M., Tornai, T., Tornai, D., Vitális, Z., Tornai, I., Antal-Szalmás, P.: Presepsin as a new biomarker for old expectations in the diagnosis and prognosis of bacterial infection in cirrhosis.
Hepatology. 62 (S1), 1227A, 2015.